HighTower Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $64.9M | Sell |
1,126,721
-26,606
| -2% | -$1.53M | 0.06% | 304 |
|
|
2026
Q1 | $69.9M | Buy |
1,153,327
+28,288
| +3% | +$1.65M | 0.07% | 270 |
|
|
2025
Q4 | $60.7M | Sell |
1,125,039
-51,078
| -4% | -$2.46M | 0.07% | 299 |
|
|
2025
Q3 | $53M | Buy |
1,176,117
+18,652
| +2% | +$871K | 0.06% | 322 |
|
|
2025
Q2 | $53.6M | Buy |
1,157,465
+226,995
| +24% | +$11.1M | 0.07% | 300 |
|
|
2025
Q1 | $56.7M | Buy |
930,470
+6,604
| +0.7% | +$385K | 0.08% | 265 |
|
|
2024
Q4 | $52.3M | Sell |
923,866
-105,099
| -10% | -$5.87M | 0.07% | 277 |
|
|
2024
Q3 | $53.2M | Buy |
1,028,965
+2,209
| +0.2% | +$104K | 0.08% | 268 |
|
|
2024
Q2 | $42.6M | Sell |
1,026,756
-198,475
| -16% | -$8.88M | 0.07% | 299 |
|
|
2024
Q1 | $66.4M | Sell |
1,225,231
-225,789
| -16% | -$11.5M | 0.11% | 208 |
|
|
2023
Q4 | $74.5M | Sell |
1,451,020
-132,566
| -8% | -$6.96M | 0.13% | 177 |
|
|
2023
Q3 | $92M | Buy |
1,583,586
+53,664
| +4% | +$3.29M | 0.17% | 127 |
|
|
2023
Q2 | $97.8M | Buy |
1,529,922
+59,531
| +4% | +$3.99M | 0.19% | 111 |
|
|
2023
Q1 | $102M | Sell |
1,470,391
-79,588
| -5% | -$5.61M | 0.22% | 95 |
|
|
2022
Q4 | $112M | Buy |
1,549,979
+62,674
| +4% | +$4.73M | 0.25% | 87 |
|
|
2022
Q3 | $106M | Sell |
1,487,305
-37,752
| -2% | -$2.74M | 0.28% | 71 |
|
|
2022
Q2 | $117M | Buy |
1,525,057
+40,596
| +3% | +$3.09M | 0.3% | 71 |
|
|
2022
Q1 | $108M | Buy |
1,484,461
+41,648
| +3% | +$2.8M | 0.24% | 90 |
|
|
2021
Q4 | $89.9M | Buy |
1,442,813
+79,370
| +6% | +$4.66M | 0.2% | 113 |
|
|
2021
Q3 | $80.7M | Buy |
1,363,443
+67,833
| +5% | +$4.47M | 0.22% | 103 |
|
|
2021
Q2 | $86.5M | Buy |
1,295,610
+61,731
| +5% | +$4.03M | 0.25% | 92 |
|
|
2021
Q1 | $77.9M | Buy |
1,233,879
+5,664
| +0.5% | +$352K | 0.25% | 95 |
|
|
2020
Q4 | $76.2M | Sell |
1,228,215
-1,606
| -0.1% | -$98.8K | 0.32% | 67 |
|
|
2020
Q3 | $74.1M | Buy |
1,229,821
+73,538
| +6% | +$4.43M | 0.36% | 59 |
|
|
2020
Q2 | $68M | Sell |
1,156,283
-37,177
| -3% | -$2.22M | 0.37% | 54 |
|
|
2020
Q1 | $66.6M | Buy |
1,193,460
+41,806
| +4% | +$2.56M | 0.43% | 45 |
|
|
2019
Q4 | $73.9M | Buy |
1,151,654
+197,645
| +21% | +$11.3M | 0.44% | 48 |
|
|
2019
Q3 | $48.4M | Buy |
954,009
+190,626
| +25% | +$8.96M | 0.26% | 80 |
|
|
2019
Q2 | $34.6M | Sell |
763,383
-79,283
| -9% | -$3.69M | 0.21% | 108 |
|
|
2019
Q1 | $40.2M | Buy |
842,666
+109,723
| +15% | +$5.47M | 0.27% | 76 |
|
|
2018
Q4 | $38.1M | Sell |
732,943
-42,746
| -6% | -$2.3M | 0.29% | 70 |
|
|
2018
Q3 | $48.1M | Sell |
775,689
-42,066
| -5% | -$2.5M | 0.35% | 58 |
|
|
2018
Q2 | $45.3M | Sell |
817,755
-115,364
| -12% | -$6.23M | 0.35% | 53 |
|
|
2018
Q1 | $59M | Sell |
933,119
-142,073
| -13% | -$9.14M | 0.49% | 37 |
|
|
2017
Q4 | $65.8M | Sell |
1,075,192
-106,182
| -9% | -$6.64M | 0.54% | 32 |
|
|
2017
Q3 | $75.3M | Buy |
1,181,374
+31,678
| +3% | +$1.85M | 0.64% | 20 |
|
|
2017
Q2 | $64.1M | Sell |
1,149,696
-52,337
| -4% | -$2.85M | 0.57% | 26 |
|
|
2017
Q1 | $65.3M | Buy |
1,202,033
+48,084
| +4% | +$2.64M | 0.63% | 22 |
|
|
2016
Q4 | $67.5M | Buy |
1,153,949
+41,545
| +4% | +$2.27M | 0.73% | 17 |
|
|
2016
Q3 | $59.9M | Buy |
1,112,404
+147,825
| +15% | +$9.5M | 0.69% | 22 |
|
|
2016
Q2 | $71M | Sell |
964,579
-34,224
| -3% | -$2.42M | 0.9% | 14 |
|
|
2016
Q1 | $63.8M | Sell |
998,803
-17,578
| -2% | -$1.11M | 0.21% | 24 |
|
|
2015
Q4 | $69.9M | Buy |
1,016,381
+31,390
| +3% | +$2.07M | 0.83% | 14 |
|
|
2015
Q3 | $58.4M | Buy |
984,991
+511,392
| +108% | +$32.4M | 0.77% | 19 |
|
|
2015
Q2 | $31.5M | Sell |
473,599
-334,556
| -41% | -$22M | 0.51% | 34 |
|
|
2015
Q1 | $52.1M | Buy |
808,155
+15,145
| +2% | +$948K | 0.78% | 17 |
|
|
2014
Q4 | $46.8M | Buy |
793,010
+3,531
| +0.4% | +$199K | 0.72% | 18 |
|
|
2014
Q3 | $40.4M | Buy |
789,479
+53,339
| +7% | +$2.66M | 0.68% | 25 |
|
|
2014
Q2 | $35.7M | Buy |
736,140
+71,347
| +11% | +$3.52M | 0.62% | 25 |
|
|
2014
Q1 | $34.5M | Buy |
664,793
+40,216
| +6% | +$2.14M | 0.67% | 22 |
|
|
2013
Q4 | $33.2M | Buy |
624,577
+38,061
| +6% | +$1.94M | 0.68% | 21 |
|
|
2013
Q3 | $27.1M | Buy |
586,516
+10,306
| +2% | +$452K | 0.68% | 24 |
|
|
2013
Q2 | $25.8M | Buy |
+576,210
| New | +$25M | 0.7% | 27 |
|
Other funds holding BMY
HighTower Advisors's BMY Position: Q2 2026 in Review
HighTower Advisors reduced its Bristol-Myers Squibb (BMY) stake by 2.3% in Q2 2026, selling an estimated $1.53M and leaving 1,126,721 shares worth $64.9M. The position accounts for 0.06% of the portfolio, ranked #304.
HighTower Advisors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $117M in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- HighTower Advisors held 1,126,721 shares of Bristol-Myers Squibb worth $64.9M as of Q2 2026.
- HighTower Advisors sold 26,606 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.53M.
- Bristol-Myers Squibb made up 0.06% of HighTower Advisors's portfolio in Q2 2026, its #304 holding.
- HighTower Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- HighTower Advisors's Bristol-Myers Squibb position peaked at $117M in Q2 2022.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.